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Abstract 
Tea, one of the most common beverages, originates from the leaves of the Camellia 
sinensis plant. Two major groups of tea are fermented black tea and unfermented green 
tea. Theaflavins (TFs) are the major polyphenols present in black tea, while mono-
palmitoyl-epigallocatechin-gallate (pEGCG) is a modified green tea polyphenol. In this 
study, the antibacterial effects of TF and pEGCG were evaluated against six selected 
bacteria, Staphylococcus epidermidis, Streptococcus mutans, Bacillus cereus, 
Escherichia coli, Pseudomonas aeruginosa and Proteus vulgaris, using an antibacterial 
assay. A viability assay using SYTOX® staining and flow cytometry was also used to 
determine the effect of these compounds on S. epidermidis and S. mutans. The anti-
biofilm effects of the compounds were also investigated using Congo red assay, resazurin 
assay, polymerase chain reaction and flow cytometry. Finally, TF and pEGCG were also 
evaluated on the effects of inhibiting sporulation and germination in Bacillus spp. The 
results indicate that 0.2% TF and 0.2% pEGCG contain strong antibacterial effects 
against all bacteria tested with an IC50 range of approximately 0.05-0.1%. In addition, the 
viability assay showed that both compounds effectively inhibit the growth of the bacteria 
as early as 3 hours and can maintain their effect for 24 hours. Results from anti-biofilm 
assays showed that TF and pEGCG are also highly effective in inhibiting the formation of 
biofilm. Qualitatively, the compounds prevented the formation of biofilm, indicated by 
the absence of black colonies on the Congo red assay. Quantitatively 0.5% and 1% 
concentrations of both TF and pEGCG inhibited biofilm formation in the four biofilm 
forming bacteria tested. PCR and gel electrophoresis was also performed to study the 
effect of TF and pEGCG on biofilm forming genes in S. epidermidis and S. mutans. 
 x 
Results indicated the presence of bands in the control sets, but absent in the treated 
samples for both sets of genes, aap and brpA. In addition, flow cytometry was used to 
further understand the effects of these compounds on S. epidermidis and S. mutans. 
Results showed that 0.5% TF is able to inhibit approximately 86% of biofilm formation 
in S. epidermidis and 88% in S. mutans, and 1% pEGCG is able to inhibit about 53% in S. 
epidermidis and 85% in S. mutans. Finally, results from sporulation and germination 
assays indicate that both compounds are capable of inhibiting these processes in spore-
forming bacteria. 1% TF and 1% pEGCG inhibit sporulation as well as the germination 
process. 1% TF inhibits approximately 77% of germination whereas 1% pEGCG inhibits 
99.9% of germination in B. cereus. These results suggest that tea polyphenols are not 
only viable antibacterial alternatives, but also potentially promising anti-biofilm and anti-
spore agents.  
 
 1 
Introduction 
 
 Recently there has been an increasing concern with the growing number of 
antibiotic resistant pathogens. Bacteria are able to desensitize against the antibiotics that 
once were able to kill them. Antibiotic resistance is a major public health problem with 
more than 2 million infections and 23,000 deaths per year caused by antibiotic-resistant 
microorganisms in the United States alone (Michaelidis et. al., 2016). Due to the 
emerging resistance to drugs by microorganisms there has been an increasing interest in 
developing new antibacterial therapies. Researchers have turned to nature and are 
studying the effects of natural antimicrobial compounds, specifically those that are plant-
derived (Friedman, 2007).  
 For centuries, medicinal plants have been used to control human diseases, and in 
the last years, there has been an increased interest in plant stimulant beverages, such as 
tea, which has shown to possess anti-cariogenic activity (Ferrazzano et. al., 2009).  
 Tea, one of the most common beverages worldwide, originates from the leaves of 
the Camellia sinensis plant (Chan et. al., 2011). Two major categories of tea are 
unfermented green tea and and fully fermented black tea. The polyphenols present in the 
two types of tea are responsible for possessing antibacterial properties. Polyphenols 
exhibit a wide range of biological effects, such as anti-inflammatory, antioxidant, 
antiviral, antibacterial, and anti-cancer (Xu et. al., 2017). In black tea the major 
polyphenol present is theaflavin (TF) and in green tea the major polyphenol is (-)-
epigallocatechin-gallate (EGCG), which in this study, was modified as mono-palmitoyl-
epigallocatechin-gallate (pEGCG). Recent literature has reported that both green tea and 
black tea have potential antimicrobial effects. 
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 Bacteria are categorized into two major groups, Gram-positive and Gram-negative 
due to the properties of their cell walls. Gram-positive bacteria possess a thick 
peptidoglycan layer in their cell wall, whereas Gram-negative bacteria possess a very thin 
peptidoglycan layer and an outer membrane containing lipopolysaccharides. Pathogenic 
gram positive bacteria include species from genera Streptococcus and Staphylococcus, 
which are both cocci, as well as spore forming bacilli, Bacillus and Clostridium. 
Although Gram-positive bacteria are typically more sensitive to antibiotics due to the 
lack of an outer membrane, some have become antibiotic resistant, the most known being 
MRSA (methicillin-resistant Staphylococcus aureus). These resistant gram-positive 
infections continue to be concerning; however, the rise in antibiotic resistant gram-
negative bacteria has now become the most pressing issue in bacterial resistance (Vasoo 
et. al., 2015). Due to the presence of an outer membrane, Gram-negative bacteria are less 
susceptible to antibiotics making them extremely pathogenic. Gram-negative bacteria 
cause various types of infections in humans, ranging from a foodborne illness all the way 
to the plague.  A few examples of Gram-positive bacteria are Staphylococcus epidermidis 
(S. epidermidis), Streptococcus mutans (S. mutans), and Bacillus cereus (B. cereus).  
 S. epidermidis is typically arranged in grape-like clusters. It is normally a part of 
the human skin flora and is usually not pathogenic. S. epidermidis is capable of forming 
biofilm, which is an important virulence factor (Vandecandelaere et. al., 2017). S. 
epidermidis also serves as a model for the Staphylococcus genus, specifically for mutant 
strains such as MRSA.  
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 S. mutans is also a Gram-positive cocci species and is arranged in a chain. It is 
typically found in the oral cavity and is known for causing dental caries due to its ability 
to also form a biofilm (dental plaque) (Subramaniam et. al., 2012).  
 B. cereus is a Gram-positive rod-shaped species capable of forming endospores. 
These spores are resistant to heat, cold, radiation, desiccation, and disinfectants 
(Turnbull, 1996), Due to the production of spores, B. cereus is most known for causing 
foodborne illnesses. The spores survive cooking or pasteurization and are able to 
germinate and multiply (Turnbull, 1996). 
 A few examples of Gram-negative bacteria are Escherichia coli (E. coli), 
Pseudomonas aeruginosa (P. aeruginosa), and Proteus vulgaris (P. vulgaris).  
 E. coli is a Gram-negative rod-shaped species found in the normal gut flora of 
animals and humans (Agin et. al., 1997). It is an opportunistic pathogen meaning that if 
introduced elsewhere it may cause serious infection. It is most known for causing 
foodborne illnesses due to fecal contamination or improper meat processing.  
 P. aeruginosa, a Gram-negative, rod-shaped bacterium, is an extremely 
opportunistic human pathogen found in soil and water. Due to its ability to thrive in moist 
environments, it is also found on medical equipment making it one of the major causes of 
nosocomial infections (Hameed et. al., 2016).   
 P. vulgaris is also a gram-negative, rod-shaped species. It is typically found in the 
intestines of humans and animals as well as in soil and water. It is also an opportunistic 
pathogen known to cause wound infections.  
 S. epidermidis, S. mutans, E. coli, and P. aeruginosa are some of the bacterial 
species studied that are capable of forming biofilms. Biofilms are complex microbial 
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communities developed on solid surfaces (Sanchez et. al., 2014). They are composed of 
colonies of bacterial cells either by the same species or a culmination of multiple species. 
The bacteria produce exopolysaccharides, which are the major component of the biofilm 
backbone and help to maintain the integrity of the biofilm as well as protecting against 
harmful agents (Saini et. al., 2015). Biofilms are unique in that the waste of one bacteria 
may be a nutrient source for another. The bacteria are able to communicate with another 
in a process known as quorum sensing. Quorum sensing involves the regulation of 
specific gene expression through the accumulation of stimuli that mediate intercellular 
communication (Saini et. al., 2015). Quorum sensing allows for the survival of the 
biofilm, such as urging the growth of beneficial bacteria and discouraging the growth of 
competitors.  
 Biofilm formation begins after successful attachment of planktonic bacterial cells 
to a solid surface. The cells produce a matrix made up of exopolysaccharides and 
continue to develop via quorum sensing. As the biofilm continues to mature, new cells 
may arrive and add to the biofilm while others might detach and go elsewhere. The 
biofilm is constantly evolving and growing making it nearly impossible to remove once it 
has successfully matured and established on a surface. The only way to effectively 
remove a biofilm is to physically scrape if off (Hayrapetyan et. al., 2015). This gives rise 
to problems since the bacteria are able to establish biofilms on medical equipment such as 
catheters and endotracheal tubes, leading to further infections in patients. In the United 
States alone, nosocomial infections (healthcare-associated infections) account for about 
1.7 million infections and 99,000 associated deaths each year (Centers for Disease 
Control and Prevention Report, 2007).  
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 Isolation and characterization of genes involved in biofilm formation may help to 
further understand the formation of biofilms. Previous studies have indicated the roles of 
sucrose and glucosyltransferases in S. mutans biofilm formation, while others have 
implicated several genes that are associated with genetic competence, such as brpA, 
which plays a regulatory role in biofilm formation (Motegi et. al., 2006). Whereas some 
genes may be directly involved in biofilm formation, such as brpA in S. mutans, others 
may be indirectly related. Many factors regarded as multifunctional proteins have 
important roles during several phases of biofilm formation and surface colonization, such 
as the accumulation associated protein (Aap) and the extracellular matrix binding protein 
(Embp) (Büttner et. al., 2015). The continued study of genes involved in biofilm 
formation may lead to ways to learn how to potentially prevent them from occurring. 
 Bacteria have different ways in order to survive. Some may produce biofilms as 
previously mentioned, whereas others, such as Bacillus and Clostridium, undergo a 
process called sporulation. Sporulation, or endospore formation, is the process where a 
cell produces a non-reproductive structure called a spore to withstand unfavorable 
conditions.  The genetic information of the mother cell is preserved in the spore. When 
the spore is reintroduced to favorable conditions, it reactivates and germinates into a new 
vegetative cell (Ali et. al., 2017). Some common illnesses due to spores are: anthrax 
caused by Bacillus anthracis, C. diff colitis caused by Clostridium difficile, and food 
poisoning caused by Bacillus cereus. Recent estimates indicate that there are 
approximately 84,000 cases of illnesses caused by B. cereus annually in the United States 
alone (Tajkarimi, 2007).  
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 The aim of this study was to investigate the antimicrobial effects of black tea 
polyphenol, TF, and green tea polyphenol, pEGCG, against six selected bacteria using 
antibacterial assay. The compounds’ inhibitory effects on biofilm formation, sporulation 
and germination were also evaluated. The anti-biofilm effects were investigated using 
Congo red assay, resazurin assay, polymerase chain reaction, and flow cytometry. The 
anti-spore effects were evaluated using sporulation and germination inhibition assays.  
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Materials and Methods 
 
Bacterial culture maintenance  
For this study, Gram-positive species: Staphylococcus epidermidis (S. epidermidis) (Item 
# 155556A), Streptococcus mutans (S. mutans) (ATCC® Number: 25175), Bacillus 
cereus (B. cereus) (Item # 154870A) and Bacillus megaterium (B. megaterium) (Item # 
154900A), and Gram-negative species, Escherichia coli (E. coli) (Item # 155065A), 
Pseudomonas aeruginosa (P. aeruginosa) (Item # 155250A), and Proteus vulgaris (P. 
vulgaris) (Item # 155240A), were obtained from Carolina Biological (Carolina, 
Burlington, NC) and ATCC® (Manassas, VA). All bacterial cultures were grown at      
37 °C with consistent shaking at 250 rpm. All cultures were maintained in Tryptic Soy 
Broth (TSB) (DifcoTM, Sparks, MD).  
 
Compound solution preparation  
Theaflavin (TF) was obtained from DH Nutraceutical, LLC. The 2% stock solution was 
made in EtOH/diH2O (1:1). Mono-palmitoyl-epigallocatechin-gallate (pEGCG) was 
obtained from Camillex, LCC (Augusta, GA). The 10% stock solution was prepared 
using DMSO. The compounds were kept at 4 °C. 
 
Antibacterial assay 
An antibacterial assay was used to observe the antibacterial effects of the natural 
compounds. The overnight bacterial cultures and 48-well clear microtiter plate were used 
in this assay. Each well contained 40 µL of bacteria and various concentration of TF 
(final concentration of 0.2%, 0.5%, and 1%) or various concentration of pEGCG (final 
 8 
concentration of 0.05%, 0.1% and 0.2%) with a total volume of 1000 µL in each well. 
The growth of the bacteria with or without natural compounds was monitored by taking 
the optical density at 600 nm (OD600nm) hourly for up to 8 hours with SpectraMax M5 
(Molecular Devices, Sunnyvale, CA). Over the monitoring period, the plate was 
maintained at 37 °C with shaking.  
 
Viability assay 
A viability assay was performed using control samples of S. epidermidis and S. mutans as 
well as cells treated with 0.5% TF, 1% pEGCG, and combination of both compounds 
(0.25% TF and 0.5% pEGCG). Cells were stained with 5 µM SYTOX® in order to detect 
dead cells. Samples were run and analyzed using MACSQuant® Analyzer 10 every 3 
hours for 24 hours.  
 
Congo red assay 
Congo red assay was performed to screen the formation of biofilm. Tryptic Soy Agar 
(TSA) (DifcoTM, Sparks, MD) with 2% sucrose (Amresco, Solon, OH) and 10X Congo 
red (Amresco, Solon, OH) were added to each well of a 24-well plate. A total of 50 µL of 
bacteria with either 50 µL TSB or 50 µL compound was added to the appropriate well. 
The plate was incubated for 24 hours at 37 °C.  
 
Resazurin assay 
Resazurin assay was performed to quantify the formation of biofilm. After incubation, 
planktonic cells were removed and the wells were washed twice with Phosphate buffered 
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saline (PBS) to remove any non-adherent cells. Following the wash, 120 µL Resazurin 
Solution was added to each well. Fluorescence was measured at λex=560 nm and λem=590 
nm at 30 minute intervals for 4 hours.  
 
DNA isolation 
The DNA extraction method presented in this paper is modified from Cheng and Jiang, 
2006 (Cheng et. al., 2006). 1 ml cell suspension was centrifuged at 8,000 x g for 2 min at 
room temperature. After removal of supernatant, cells were washed twice with 400 L 
STE Buffer (100 mM NaCl, 10 mM Tris-HCl, and 1 mM EDTA, pH 8.0) and centrifuged 
again at 8,000 x g for 2 min at room temperature. After removal of supernatant, cells 
were resuspended in 200 µL 1X TE (10 mM Tris-HCl, 1 mM EDTA, pH 8.0). 100 µL 
Phenol:Chloroform:Isoamyl Alcohol (25:24:1; pH 8.0) was added, followed by a vortex-
mixing step for 90 s. The samples were subsequently centrifuged at 13,000 x g for 5 min 
at 4 °C to separate the aqueous phase from organic phase. 140 µL upper aqueous phase 
was transferred to a clean 1.5 mL tube. 60 µL 1X TE was added to the tube followed by 
100 µL Chloroform. Tubes were mixed by rapid inversion multiple times and centrifuged 
again at 13,000 x g from 5 min at 4 °C to separate upper aqueous phase from lower 
organic phase. 140 µL of upper aqueous phase was transferred to a new 1.5 mL 
microfuge tube. 55 L 1X TE and 5 µL RNase (2 mg/mL RNase A/5000 u/mL RNase 
T1) were added and incubated at 37 °C for 10 min to digest RNA. 100 µL chloroform 
was added to the tube, mixed well and centrifuged for 5 min at 13,000 x g at 4 °C. 140 
µL of upper aqueous phase was transferred to new 1.5 mL tube. 60 µL 1X TE and 100 
µL chloroform were added followed by centrifugation again at 13,000 x g for 5 min at 4 
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°C. This was repeated a total of 3 times. The final aqueous phase containing purified 
DNA was stored at -20 °C. The purity and yield of the DNA were assessed using the 
A260/A280 reading.  
 
Polymerase chain reaction (PCR) and gel electrophoresis  
Positive control was prepared by adding 2.5 µL DMSO, 6 µL nuclease free dH2O, 12.5 
µL 2x Master Mix (Promega and 2x GoTaq), 1 µL 400nM forward primer, 2 µL DNA 
Template, and 1 µL 400 nM reverse primer. Negative control was prepared by adding 2.5 
µL DMSO, 8 µL nuclease free dH2O, 12.5 µL 2x Master Mix (Promega and 2x goTaq), 1 
µL 400nM forward primer, and 1 µL 400nM reverse primer. Samples were spun down 
with an annealing time of 45 seconds. Samples were loaded and ran through 35 cycles of 
PCR. Gel was prepared with 1% Agarose in 1X TAE.  
 
Biofilm viability study with SYTOX®  
Flow cytometry was performed to determine the effect of TF and pEGCG on biofilm 
inhibition of S. epidermidis and S. mutans. Bacteria were treated with 0.5% TF, 1% 
pEGCG, and combination of both compounds (0.25% TF and 0.5% pEGCG). Samples 
were incubated at 37 °C for 24 hours to allow biofilm formation to occur. After 
incubation, cells were stained with 5 µM SYTOX® and analyzed using MACSQuant® 
Analyzer 10. 
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Sporulation inhibition assay 
Spore-forming bacteria, B. cereus, was starved with diH2O, 1% TF or 1% pEGCG and 
for 24 hours. Schaeffer-Fulton stain procedure was performed to observe spore formation 
inhibition.  
 
Germination inhibition assay 
B. cereus was starved in diH2O for 48 hours to induce spore formation. The cultures were 
then split into two tubes: TSB only and TSB with TF (1% final concentration) or TSF 
with pEGCG (1% final concentration). Tubes were then incubated at 37 °C at 250 rpm 
for 6 hours. Viable count was then used to determine viable cells.  
 
Statistical analysis 
All experiments were performed in triplicate and statistical analyses were carried out 
using Student’s t-test. Results with p values less than 0.05 are considered statistically 
significant.  
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Results 
 
Antibacterial assay  
 
 Six selected bacteria, three gram positive and three gram negative, were treated 
with or without TF and pEGCG in order to demonstrate the effect of these compounds on 
bacterial growth. Figures 1-6 illustrate the growth curves of these bacteria with different 
concentrations of TF and pEGCG. Figure 1A shows the growth curve of S. epidermidis 
with various concentrations of TF. The treatment of TF on S. epidermidis compared to 
control (no treatment) showed significant inhibition of growth demonstrating the 
antibacterial effect of the compound (p = 0.005). Figure 1B shows the growth curve of S. 
epidermidis treated with various concentrations of pEGCG. This figure provides 
information on the minimum inhibitory concentration (MIC) and the Inhibitory 
Concentration 50% (IC50) of the compound. The results indicate that the MIC for S. 
epidermidis, is 0.2% pEGCG showing a significant inhibition of growth (p = 0.00045) 
with an IC50 of 0.1% pEGCG.  
 Figures 2A and 2B show the effect of TF and pEGCG on S. mutans. TF 
effectively inhibits the growth of S. mutans at all concentrations. A 0.2% concentration of 
pEGCG significantly inhibits the growth of S. mutans completely (p = 0.013), and the 
IC50 is 0.1% pEGCG. Figure 3 indicates that both TF and pEGCG are effective in 
inhibiting B. cereus. TF had a MIC of 0.2% and pEGCG with a MIC of 0.2% and IC50 of 
0.1%.  
 Figures 4-6 demonstrate the effect of TF and pEGCG on three gram-negative 
species, E. coli, P. vulgaris, and P. aeruginosa. Figure 4A shows that all concentrations 
of TF inhibit the growth of E. coli, with a MIC of 0.2%. Figure 4B denotes that 0.2% 
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pEGCG is the MIC and 0.1% pEGCG is the IC50. TF and pEGCG are also effective in 
inhibiting the growth of P. aeruginosa and P. vulgaris with concentrations of 0.2% 
(Figures 5 and 6).  
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Figure 1. Growth curve of S. epidermidis A) S. epidermidis treated with various 
concentrations of TF. B) S. epidermidis treated with various concentrations of pEGCG.  
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Figure 2. Growth curve of S. mutans A) S. mutans treated with various concentrations 
of TF. B) S. mutans treated with various concentrations of pEGCG.  
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Figure 3. Growth curve of B. cereus A) B. cereus treated with various concentrations of 
TF. B) B. cereus treated with various concentrations of pEGCG.  
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Figure 4. Growth curve of E. coli A) E. coli treated with various concentrations of TF. 
B) E. coli treated with various concentrations of pEGCG.  
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Figure 5. Growth curve of P. aeruginosa A) P. aeruginosa treated with various 
concentrations of TF. B) P. aeruginosa treated with various concentrations of pEGCG.  
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Figure 6. Growth curve of P. vulgaris A) P. vulgaris treated with various 
concentrations of TF. B) P. vulgaris treated with various concentrations of pEGCG.  
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Table 1. MIC and IC50 concentrations of TF and pEGCG for 6 bacterial species. 
 
 Theaflavin (TF) Palmitoyl-EGCG (pEGCG) 
 MIC IC50 MIC IC50 
S. epidermidis 0.2% < 0.2% 0.2% 0.05-0.1% 
S. mutans 0.2% < 0.2% 0.2% ~ 0.1% 
B. cereus 0.2% < 0.2% 0.2% ~ 0.1% 
E. coli 0.2% < 0.2% 0.2% ~ 0.1% 
P. aeruginosa 0.2% < 0.2% 0.2% ~ 0.1% 
P. vulgaris 0.2% < 0.2% 0.2% < 0.2% 
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Viability assay  
 
 To further understand the effect of these compounds on the bacteria, a time-
coursed study was performed where S. epidermidis and S. mutans were stained with 
SYTOX® and were monitored every 3 hours with MACSQuant® Analyzer 10 flow 
cytometer. In Figure 7, TF is able to significantly inhibit S. epidermidis as quickly as 3 
hours (p = 8.3 x 10-6), whereas pEGCG is more effective at 6 hours. Both compounds are 
able to hold their effect for up to 24 hours after initial treatment. In Figure 8, TF is 
significantly inhibiting S. mutans at 3 hours and is able to hold that effect for 24 hours (p 
= 4.2 x 10-6), where pEGCG is most effective at 24 hours.  
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Figure 7. Percent viability of S. epidermidis. The percent viability of the compounds on 
S. epidermidis at 3 hour intervals.  
 
 
 
 
Figure 8. Percent viability of S. mutans. The percent viability of the compounds on S. 
mutans at 3 hour intervals.  
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Congo red assay 
 A qualitative assay was performed using Congo red to detect the production of a 
biofilm. When a biofilm is formed, the Congo red media will form black colonies. Two 
known biofilm forming bacteria were selected for this assay, S. epidermidis and S. 
mutans. The bacteria were treated with either 1% TF or 2% pEGCG to test the effect of 
these compounds on biofilm formation. Both TF and pEGCG inhibited S. epidermidis 
from forming a biofilm and TF was also able to inhibit S. mutans from forming a biofilm 
(results not shown).  
 
Resazurin assay 
 Results from the Congo red assay suggested that TF and pEGCG are effective in 
inhibiting biofilm formation. A quantitative assay using Resazurin was carried out to 
quantify biofilm reduction. Resazurin is a blue compound that is reduced to a pink 
fluorescent resorfin in the presence of a biofilm (O’Brian et al., 2000). Four biofilm-
forming bacteria were selected for this assay: S. epidermidis, S. mutans, E. coli, and P. 
aeruginosa. TF at concentrations of 0.5% and 1% show to be the most effective in 
significantly inhibiting the production of biofilm in S. epidermidis (p = 0.0011 and p = 
0.0012) (Figure 9A) with a percent inhibition of approximately 99.9% for both 
concentrations (Figure 9B). 0.2% TF is less effective with a percent inhibition of 
approximately 50%. In comparison, all concentrations of pEGCG (0.2%, 0.5%, and 1%) 
were equally effective in inhibiting S. epidermidis biofilm formation with a percent 
inhibition of approximately 99.9% (Figure 10).  In Figure 11, all concentrations of TF are 
able to inhibit the production of biofilm in S. mutans species with 99.9% inhibition. 0.5% 
and 1% pEGCG are significantly effective in inhibiting S. mutans biofilm formation (p = 
 24 
0.00025 and p = 0.00026); 0.2% pEGCG is the least effective in inhibiting biofilm 
formation (Figure 12). In Figure 13 and 15, all concentrations of TF (0.2, 0.5 and 1%) 
were effective in inhibiting biofilm formation in E. coli (Figure 13B) and P. aeruginosa 
(Figure 15B), whereas only 0.5 and 1% pEGCG were effective in inhibiting biofilm 
formation (Figures 14 and 16). 0.2% pEGCG did not inhibit biofilm production in E. coli 
(Figure 14B) and P. aeruginosa (Figure 16B).  
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Figure 9. Resazurin assay of S. epidermidis with TF A) S. epidermidis treated with 
various concentrations TF. B) Percent Inhibition of TF on S. epidermidis biofilm 
formation. 
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Figure 10. Resazurin assay of S. epidermidis with pEGCG A) S. epidermidis treated 
with various concentrations of pEGCG. B) Percent Inhibition of pEGCG on S. 
epidermidis biofilm formation. 
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Figure 11. Resazurin assay of S. mutans with TF A) S. mutans treated with various 
concentrations of TF. B) Percent Inhibition of TF on S. mutans biofilm formation. 
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Figure 12. Resazurin assay of S. mutans with pEGCG A) Streptococcus mutans 
treated with various concentrations of pEGCG. B) Percent Inhibition of pEGCG on S. 
mutans biofilm formation. 
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Figure 13. Resazurin assay of E. coli with TF A) E. coli treated with various 
concentrations of TF. B) Percent Inhibition of TF on E. coli biofilm formation. 
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Figure 14. Resazurin assay of E. coli with pEGCG A) E. coli treated with various 
concentrations of pEGCG. B) Percent Inhibition of pEGCG on E. coli biofilm formation. 
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Figure 15. Resazurin assay of P. aeruginosa with TF A) P. aeruginosa treated with 
various concentrations of TF. B) Percent Inhibition of TF on P. aeruginosa biofilm 
formation. 
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Figure 16. Resazurin assay of P. aeruginosa with pEGCG A) P. aeruginosa treated 
with various concentrations of pEGCG. B) Percent Inhibition of pEGCG on P. 
aeruginosa biofilm formation. 
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Polymerase chain reaction (PCR) and gel electrophoresis 
  
 Based on both the Congo red and Resazurin results, it is apparent that TF and 
pEGCG are capable of inhibiting biofilm formation; however, the mechanism in which 
these compounds work is not well understood. Primers were designed for genes involved 
in biofilm formation for two selected bacteria, S. epidermidis and S. mutans, to determine 
whether these compounds work at the molecular level. The aap gene for S. epidermidis 
and the brpA gene for S. mutans were observed. Primers for these genes were designed 
using NCBI. The genes responsible for biofilm formation in S. epidermidis were studied, 
yielding two sets of primers: aap_f, aap_r, Similarly, the gene responsible for biofilm 
formation in S. mutans yielded primers: brpA_2f, brpA_2r, brpA_3f, brpA_3r (Figure 17). 
DNA was isolated from S. epidermidis and S. mutans without treatment of compounds as 
well as treatment with 0.5% TF, 1% pEGCG, and a combination of TF and pEGCG. Gel 
electrophoresis was performed to observe the effect of these compounds. The aap gene 
for S. epidermidis was present in the control with a band at 524bp; however when S. 
epidermidis was treated with TF, pEGCG, and the TF/pEGCG combination, the band was 
no longer present (Figure 18). The brpA gene for S. mutans was present in the control for 
both sets of primers, but was absent in all the samples treated with TF, pEGCG and 
TF/pEGCG combination (Figure 19). 
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Figure 17. Primer design. Two sets of primers (forward and reverse) were designed for 
the selected genes responsible for biofilm formation in S. epidermidis and S. mutans. A) 
S. epidermidis primers: aap_f + aap_r. B) S. mutans primers: brpA_2f + brpA_2r and 
brpA_3f + brpA_3r 
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Figure 18. Gel electrophoresis on S. epidermidis biofilm gene. PCR was performed to 
amplify genes of interest. The aap gene responsible for biofilm formation in S. 
epidermidis was observed under control and treated conditions 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19. Gel electrophoresis on S. mutans biofilm gene. PCR was performed to 
amplify genes of interest. The brpA gene responsible for biofilm formation in S. mutans 
was observed under control and treated conditions. 
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Biofilm viability study with SYTOX®  
 To further understand the effect of TF and pEGCG on the production of biofilm in 
S. epidermidis and S. mutans, a viability assay using flow cytometry was performed. In 
this study, the bacteria were stained with SYTOX®. S. epidermidis and S. mutans were 
treated with 0.5% TF, 1% pEGCG, and a combination of the two compounds. The 
compounds are all shown to be effective in inhibiting the production of biofilm in S. 
epidermidis. TF is shown to inhibit approximately 86% of the biofilm formation in S. 
epidermidis, pEGCG inhibits approximately 57% and the combination of the two 
compounds inhibits 73% (Figure 20). Results show that the compounds are also effective 
in inhibiting biofilm formation in S. mutans. TF inhibits approximately 88% and pEGCG 
inhibits about 85% of biofilm formation in S. mutans. The TF/pEGCG combination, 
however, only inhibits about 62% (Figure 21).  
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Figure 20. Percent inhibition of TF and pEGCG on S. epidermidis. The percent 
inhibition of the compounds on S. epidermidis was calcaluated based on the flow 
cytometry results. Asterisk (*) indicates statistically significant (p < 0.05).  
 
 
 
 
Figure 21. Percent inhibition of TF and pEGCG on S. mutans. The percent inhibition 
of the compounds on S. mutans was calcaluated based on the flow cytometry results. 
Asterisk (*) indicates statistically significant (p < 0.05). 
86.7
57.9
73.6
0
10
20
30
40
50
60
70
80
90
100
TF pEGCG Combination
%
 in
h
ib
it
io
n
*
*
*
88.3
84.7
61.9
0
10
20
30
40
50
60
70
80
90
100
TF pEGCG Combination
%
 In
h
ib
it
io
n
*
*
*
 38 
Sporulation inhibition assay 
 B. megaterium and B. cereus were treated with TF and pEGCG in order to 
determine the effect of the compounds on sporulation. B. megaterium and B. cereus 
cultures were centrifuged and resuspended in either: diH2O, TF or pEGCG for 24 hrs. A 
spore stain was performed in order to observe the effect of the compounds on sporulation 
for these two spore-forming bacteria. In Figure 22, spores are present in the control (A 
and D), but are absent in the treated cells; therefore indicating that the compounds, TF 
and pEGCG, are able to inhibit the process of sporulation in both Bacillus spp.  
  
 39 
 
 
 
Figure 22. Microscopic observations: spore stain. A) B. megaterium control B) B. 
megaterium treated with 1% TF C) B. megaterium treated with 1% pEGCG D) B. cereus 
control E) B. cereus treated with 1% TF F)  B. cereus treated with 1% pEGCG 
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Germination inhibition assay 
 TF and pEGCG have both shown to be effective in inhibiting biofilm formation 
and sporulation. The effects of these compounds on inhibiting germination in spore-
forming bacteria were also studied. In this study, B. cereus was used to evaluate the 
germination process (Figure 23A). TF is able to inhibit approximately 76% of 
germination with a log fold reduction of 1.77, and pEGCG inhibits approximately 99.9% 
of the process in B. cereus, which is a log fold reduction of 3.44 (Figure 23B).  
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Figure 23. Germination inhibition assay. A) Colonies were seen up to the 10-7 dilution 
in the control plates, 10-6 dilution for the plates treated with 1% TF, and 10-5 dilution for 
the plates treated with 1% pEGCG. B) The percent inhibition of the compounds on B. 
cereus was calcaluated based on the viable count.  
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Discussion 
 
 As of late, the increase in antibiotic resistant pathogens has led to the interest in 
studying natural compounds, plant-derived in particular, as potential therapeutic agents. 
For millennia, tea has been used as a medicinal beverage, especially in its native country 
of China (Ferrazzano et. al., 2009). Tea is characterized by the presence of phenolic 
catechins such as epigallocatechin-3-gallate (EGCG), the major polyphenol in green tea. 
During fermentation, these catechins are oxidized yielding secondary polyphenols such 
as theaflavins, the major polyphenols in black tea (Ferrazzano et. al., 2009). In this study, 
the antibacterial effects of black tea and green tea polyphenols, theaflavin (TF) and 
palmitoyl-EGCG (pEGCG), were evaluated against a variety of bacteria and their specific 
defense mechanisms including biofilm and spore formation.  
 The results from the antibacterial assay showed that at 0.2% concentration of both 
TF and pEGCG effectively inhibited the growth of bacteria (Figures 1-6). Therefore the 
minimum inhibitory concentration (MIC) for both compounds is 0.2% for all bacteria 
tested. It can also be observed that the IC50 for TF for most of the selected bacteria is less 
than 0.2% and for pEGCG the range is between 0.05 - 0.1% (Table 1). These results 
indicate that the compounds are capable of inhibiting the growth of bacteria. The results 
from the viability assay using flow cytometry showed that both compounds, TF and 
pEGCG, are effective after a 3 hour treatment and are able to maintain their effect for up 
to 24 hours (Figure 7 and 8). These results further conclude that these compounds possess 
antibacterial properties against both gram negative and gram positive bacteria.  
 Due to the rise in nosocomial infections caused by bacterial biofilms, the anti-
biofilm effects of TF and pEGCG were also evaluated. Four bacteria that are known to 
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cause biofilms, S. epidermidis, S, mutans, E. coli, and P. aeruginosa, were studied using 
Congo-red and resazurin assays. Congo-red is an indicator dye; when a bacteria is 
inoculated and incubated on Congo-red media, the formation of black colonies indicates 
the presence of biofilm formation. In the same sense, resazurin is also an indicator. The 
resazurin assay is based on the reduction of resazurin by metabolically active cells, where 
the blue compound is reduced to a fluorescent pink resorufin (Peeters et. al., 2008). The 
fluorescence is measured using a spectrophotometer, which then indicates the presence of 
biofilm formation. The results from the resazurin assay indicate that both TF and pEGCG 
are effective in inhibiting the formation of biofilm in the four selected bacteria (Figures 9 
– 16).   
 Although it is inferred that TF and pEGCG are capable of inhibiting the formation 
of biofilm, the mechanism in which these compounds work is not completely understood. 
In order to further understand how these compounds are inhibiting the production of 
biofilm, molecular analysis was conducted. Two bacteria were selected for this study, 
Staphylococcus epidermidis and Streptococcus mutans. S. epidermidis is a model 
organism for its pathogenic family member, Staphylococcus aureus, which is capable of 
becoming antibiotic resistant, the most known strain being methicillin-resistant 
Staphylococcus aureus (MRSA). Streptococcus mutans is one of the major causing 
agents of dental plaque and dental caries. Genes that are involved in biofilm formation 
for each of these bacteria were identified and tested. The brpA gene plays a regulatory 
role in biofilm formation in S. mutans, and the aap gene, which produces an 
accumulation associated protein (Aap) that is involved in biofilm formation in S. 
epidermidis. The results from the polymerase chain reaction (PCR) and gel 
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electrophoresis studies showed that TF, pEGCG and a combination of TF and pEGCG 
effect the presence of these genes compared to the control (Figure 18 – 19).  
 Although the use of Congo-red, resazurin and PCR are effective in showing the 
effect of TF and pEGCG on biofilm formation, these methods are typically time 
consuming. In an effort to be able to rapidly detect the effects of these compounds on 
biofilm formation, flow cytometry was used. Flow cytometry offers a multi-parametric 
description of individual cells, which can be applied to study microbial communities 
(Rubbens et. al., 2017). S. epidermidis and S. mutans biofilms were stained with 
SYTOX®, a Live/Dead stain. Results showed that S. epidermidis biofilm was inhibited 
86.7% with TF, 52.9% with pEGCG and 73.6% with TF/pEGCG combination (Figure 
20). This indicates that TF alone is able to inhibit majority of biofilm formation in S. 
epidermidis. pEGCG is not as effective in inhibiting biofilm formation alone, but in 
combination with TF is able to increase percent inhibition. S. mutans biofilm was 
inhibited 88.3% with TF, 84.7% with pEGCG, and 61.9% with TF/pEGCG combination 
(Figure 21). These results indicate that TF and pEGCG are more effective in inhibiting 
biofilm formation alone. The combination of the two compounds was less effective in 
inhibiting biofilm formation.  
 Recently, microbiologists, food safety researchers, and the general public, to 
name a few, are concerned with the growing number of foodborne illness outbreaks 
caused by pathogens, such as Bacillus cereus (Friedman, 2006). Bacillus spp. are capable 
of producing spores, which are able to withstand harsh conditions. In this study, B. 
megaterium and B. cereus were first treated with 1% TF and 1% pEGCG, to observe the 
potential effectiveness in inhibiting sporulation (Fig. 22). Figure 22A and Figure 22D 
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represent the control sample, where B. megaterium and B. cereus are untreated with 
diH2O to induce the cells to sporulate. When the cells were treated with the compounds, 
TF and pEGCG, there is a decrease in spores present in the samples indicating that the 
compounds are effective in inhibiting sporulation of these bacterial cells.  
 Once it was observed that these compounds were effective in inhibiting 
sporulation, they were then tested for their effectiveness of inhibiting germination. 
Bacillus cereus spores were treated with TSB, 1% TF and 1% pEGCG to allow for 
germination to occur. Based on the results of the viable plate count (Fig. 23A), it was 
calculated that TF showed 76.6 % inhibition and pEGCG had 99.9 % inhibition (Fig. 
23B). This indicates that pEGCG was more effective in inhibiting germination of B. 
cereus spores compared to TF. 
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